These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction. Daniłowicz-Szymanowicz L; Kaufmann D; Rozwadowska K; Kempa M; Lewicka E; Raczak G PLoS One; 2018; 13(5):e0196812. PubMed ID: 29723261 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry. Tsai VW; Cooper J; Garan H; Natale A; Ptaszek LM; Ellinor PT; Hickey K; Downey R; Zei P; Hsia H; Wang P; Hunt S; Haddad F; Al-Ahmad A Circ Heart Fail; 2009 May; 2(3):197-201. PubMed ID: 19808340 [TBL] [Abstract][Full Text] [Related]
6. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Klein H; Auricchio A; Reek S; Geller C Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive imaging markers associated with sudden cardiac death. van der Bijl P; Delgado V; Bax JJ Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012 [TBL] [Abstract][Full Text] [Related]
8. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy. Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421 [TBL] [Abstract][Full Text] [Related]
10. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications. Wu KC Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807 [TBL] [Abstract][Full Text] [Related]
11. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death]. Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768 [TBL] [Abstract][Full Text] [Related]
12. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970 [TBL] [Abstract][Full Text] [Related]
13. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality. Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139 [TBL] [Abstract][Full Text] [Related]
14. Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: implications for identifying patients at risk for sudden cardiac death. Amit G; Rosenbaum DS; Super DM; Costantini O Heart Rhythm; 2010 Jun; 7(6):763-8. PubMed ID: 20156592 [TBL] [Abstract][Full Text] [Related]
15. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications. Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093 [TBL] [Abstract][Full Text] [Related]
16. LifeMap: towards the development of a new technology in sudden cardiac death risk stratification for clinical use. Ng GA; Mistry A; Li X; Schlindwein FS; Nicolson WB Europace; 2018 Sep; 20(FI2):f162-f170. PubMed ID: 29684162 [TBL] [Abstract][Full Text] [Related]
18. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy. Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132 [TBL] [Abstract][Full Text] [Related]
19. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826 [TBL] [Abstract][Full Text] [Related]
20. Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge. Weissler-Snir A; Adler A; Williams L; Gruner C; Rakowski H Eur Heart J; 2017 Jun; 38(22):1728-1737. PubMed ID: 27371714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]